col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer-Verlag: Journal of Clinical Immunology
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―15 Prolonged Fecal Shedding of SARS-CoV-2 in Asymptomatic Children with Inborn Errors of Immunity Madhu Chhanda Mohanty, Prasad D. Taur, Unnati Prashant Sawant, Reetika Malik Yadav, Varsha Potdar
2 [GO] 2021―Aug―23 Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection Mathieu Paul Rodero, Stéphane Pelleau, Anne Welfringer-Morin, Darragh Duffy, Isabelle Melki, Brigitte Bader-Meunier, et al. (+10)
3 [GO] 2021―Aug―21 Self-Limited COVID-19 in a Patient with Artemis Hypomorphic SCID Stanislaw J. Gabryszewski, Ross N. England, Di Sun, Tatiana Londoño Gentile, William Hochgertel, Soma Jyonouchi, et al. (+4)
4 [GO] 2021―Jul―26 Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection? Mark Kacar, Paulina Cortes-Acevedo, Vinesh Patel, Clive Carter, Pamela Hughes, Hugh P. McGann, et al. (+5)
5 [GO] 2021―Jul―21 Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies Jacqueline D. Squire, Avni Y. Joshi
6 [GO] 2021―Jul―17 Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study Javier García-Abellán, Sergio Padilla, Marta Fernández-González, José A. García, Vanesa Agulló, María Andreo, et al. (+4)
7 [GO] 2021―Jul―15 Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit Monia Ouederni, Samia Rekaya, Oussema Boꯚllah, Ilhem Ben Fradj, Ridha Kouki, Yosr Chebbi, et al. (+11)
8 [GO] 2021―Jul―07 Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality Maaweya E. Hamed, Asif Naeem, Haitham Alkadi, Aref A. Alamri, Ahmad S. AlYami, Abdullah AlJuryyan, et al. (+5)
9 [GO] 2021―Jul―06 COVID-19 in Patients with Primary Immunodeficiency Saliha Esenboga, Melike Ocak, Ayşegul Akarsu, Hacer Neslihan Bildik, Deniz Cagdas, Arzu Topeli Iskit, Ilhan Tezcan
10 [GO] 2021―Jun―26 SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist Alizée Bozonnat, Florence Assan, Jérôme LeGoff, Emmanuelle Bourrat, Hervé Bachelez
11 [GO] 2021―Jun―25 SARS-CoV-2-Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease Bandar Al-Saud, Khaled M. Hazzazi, Reem Mohammed, Alaa Al Najjar, Tariq Al Hazmi, Dorota Monies, Fowzan S. Alkuraya
12 [GO] 2021―Jun―23 Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study Ekaterini Simões Goudouris, Fernanda Pinto-Mariz, Leonardo Oliveira Mendonça, Carolina Sanchez Aranda, Rafaela Rolla Guimarães, Cristina Kokron, et al. (+33)
13 [GO] 2021―Jun―10 COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico Lina M. Castano-Jaramillo, Marco Antonio Yamazaki-Nakashimada, Patricia M. O’Farrill-Romanillos, David Muzquiz Zermeño, Selma C. Scheffler Mendoza, Edna Venegas Montoya, et al. (+14)
14 [GO] 2021―Jun―09 SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance? Paloma Guisado Hernández, Pilar Blanco Lobo, Isabel Villaoslada, Beatriz de Felipe, José M. Lucena, Guillermo Martín Gutierrez, et al. (+6)
15 [GO] 2021―Jun―08 Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β Donald C. Vinh, Laurent Abel, Paul Bastard, Matthew P. Cheng, Antonio Condino-Neto, Peter K. Gregersen, et al. (+28)
16 [GO] 2021―Jun―05 Atypical Inflammatory Syndrome Triggered by SARS-CoV-2 in Infants with Down Syndrome Louise Malle, Paul Bastard, Andrea Martin-Nalda, Taya Carpenter, Douglas Bush, Roosheel Patel, et al. (+6)
17 [GO] 2021―May―29 MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population Shay Ben Shachar, Noam Barda, Sigal Manor, Sapir Israeli, Noa Dagan, Shai Carmi, et al. (+3)
18 [GO] 2021―May―19 Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma Sara E. Vazquez, Paul Bastard, Kathleen Kelly, Adrian Gervais, Philip J. Norris, Larry J. Dumont, et al. (+3)
19 [GO] 2021―May―13 Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency Hannah Kinoshita, Jessica Durkee-Shock, Mariah Jensen-Wachspress, Vaishnavi V. Kankate, Haili Lang, Christopher A. Lazarski, et al. (+10)
20 [GO] 2021―May―05 Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia Che-Mai Chang, Po-Hao Feng, Tsung-Hsun Wu, Houda Alachkar, Kang-Yun Lee, Wei-Chiao Chang
21 [GO] 2021―May―03 SARS-CoV-2 Infection in a Child with Severe Congenital Neutropenia Pandiarajan Vignesh, Sanjib Mondal, Murugan Sudhakar, Yogish Kumar Sharma, Arun Bansal, Mini Singh, Man Updesh Singh Sachdeva
22 [GO] 2021―Apr―16 Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection-Implications for Therapeutic Monitoring and Therapeutic Targets George P. Drewett, Ana Copaescu, Effie Mouhtouris, Natalie Hannan, Fiona James, Olivia Smibert, et al. (+2)
23 [GO] 2021―Apr―13 Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain Jesús Troya, Paul Bastard, Laura Planas-Serra, Pablo Ryan, Montse Ruiz, María de Carranza, et al. (+5)
24 [GO] 2021―Mar―31 Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia Emily McKemey, Adrian M. Shields, Sian E. Faustini, Harriet J. Hill, Aliaksandra Baranskaya, Zania Stamataki, et al. (+4)
25 [GO] 2021―Mar―25 Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2 Paul Bastard, Romain Lévy, Soledad Henriquez, Christine Bodemer, Tali-Anne Szwebel, Jean-Laurent Casanova
26 [GO] 2021―Mar―16 Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses Jennifer Hicks, Carleen Klumpp-Thomas, Heather Kalish, Anandakumar Shunmugavel, Jennifer Mehalko, John-Paul Denson, et al. (+8)
27 [GO] 2021―Feb―22 Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia Nicolas de Prost, Paul Bastard, Romain Arrestier, Slim Fourati, Mathieu Mahévas, Sonia Burrel, et al. (+9)
28 [GO] 2021―Feb―21 Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia Emily McKemey, Adrian M. Shields, Sian E. Faustini, Harriet J. Hill, Aliaksandra Barnskaya, Zania Stamataki, et al. (+4)
29 [GO] 2021―Feb―08 A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma Aled Iaboni, Natalie Wong, Stephen D. Betschel
30 [GO] 2021―Jan―21 C1 Esterase Inhibition: Targeting Multiple Systems in COVID-19 T. M. Ayodele Adesanya, Courtney M. Campbell, Lijun Cheng, Princess U. Ogbogu, Rami Kahwash
31 [GO] 2021―Jan―20 Correction to: IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2 Romain Lévy, Paul Bastard, Fanny Lanternier, Marc Lecuit, Shen-Ying Zhang, Jean-Laurent Casanova
32 [GO] 2021―Jan―18 Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19 Veronica Azmy, Kelsey Kaman, Daiwei Tang, Hongyu Zhao, Charles Dela Cruz, Jeffrey E. Topal, et al. (+2)
33 [GO] 2021―Jan―15 The Impact of the SARS-CoV-2 Pandemic in PID Patients Receiving Ig Replacement Therapy Sukru Cekic, Fatih Cicek, Sara Sebnem Kilic
34 [GO] 2021―Jan―04 Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France Julie Toubiana, Jérémie F. Cohen, Joséphine Brice, Clément Poirault, Fanny Bajolle, William Curtis, et al. (+7)
35 [GO] 2021―Jan―03 IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2 Romain Lévy, Paul Bastard, Fanny Lanternier, Marc Lecuit, Shen-Ying Zhang, Jean-Laurent Casanova
36 [GO] 2021―Jan―02 SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage Florian Reizine, Mathieu Lesouhaitier, Murielle Gregoire, Kieran Pinceaux, Arnaud Gacouin, Adel Maamar, et al. (+22)
37 [GO] 2020―Dec―01 Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency Samaneh Delavari, Hassan Abolhassani, Farhad Abolnezhadian, Fateme Babaha, Sara Iranparast, Hamid Ahanchian, et al. (+23)
38 [GO] 2020―Nov―27 N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects Cristiane J. Nunes-Santos, Hye Sun Kuehn, Sergio D. Rosenzweig
39 [GO] 2020―Nov―26 A Case-Control Study of the 2019 Influenza Vaccine and Incidence of COVID-19 Among Healthcare Workers Nilofar Massoudi, Babak Mohit
40 [GO] 2020―Nov―24 The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19 Enric Monreal, Susana Sainz de la Maza, Jose Ignacio Fernández-Velasco, Elena Natera-Villalba, Claudia Geraldine Rita, Fernando Rodríguez-Jorge, et al. (+14)
41 [GO] 2020―Nov―20 Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy Jonathan London, David Boutboul, Karine Lacombe, France Pirenne, Beate Heym, Valérie Zeller, et al. (+3)
42 [GO] 2020―Nov―14 Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis Mathilde Roumier, Romain Paule, Alexandre Vallée, Julien Rohmer, Marie Ballester, Anne-Laure Brun, et al. (+22)
43 [GO] 2020―Oct―31 Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis Wanvisa Udomsinprasert, Jiraphun Jittikoon, Sermsiri Sangroongruangsri, Usa Chaikledkaew
44 [GO] 2020―Oct―27 Recovery from COVID-19 in a Child with Chronic Granulomatous Disease and T Cell Lymphopenia Vasudha Mantravadi, Suong T. Nguyen, S. Celeste Morley, Jeffrey J. Bednarski, Maleewan Kitcharoensakkul, Megan A. Cooper
45 [GO] 2020―Aug―22 Unraveling the Immune Response in Severe COVID-19 Lucie Rodriguez, Petter Brodin
46 [GO] 2020―Aug―22 Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome Lila Bouadma, Aurélie Wiedemann, Juliette Patrier, Mathieu Surénaud, Paul-Henri Wicky, Emile Foucat, et al. (+8)
47 [GO] 2020―Jul―13 Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection Ying Luo, Liyan Mao, Xu Yuan, Ying Xue, Qun Lin, Guoxing Tang, et al. (+3)
48 [GO] 2020―Jul―10 Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm Shima Mahmoudi, Mitra Rezaei, Nahal Mansouri, Majid Marjani, Davood Mansouri
49 [GO] 2020―Jun―28 Flow Cytometry Identifies Risk Factors and Dynamic Changes in Patients with COVID-19 Daniele Moratto, Marco Chiarini, Viviana Giustini, Federico Serana, Paola Magro, Aldo Maria Roccaro, et al. (+4)


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.011 sec